Search Results - "Higo, Tomoaki"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Homogeneous 2D and 3D alignment of cardiomyocyte in dilated cardiomyopathy revealed by intravital heart imaging by Masuyama, Kiyoshi, Higo, Tomoaki, Lee, Jong-Kook, Matsuura, Ryohei, Jones, Ian, Bakal, Chris, Higo, Shuichiro, Morimoto, Sachio, Miyagawa, Shigeru, Sawa, Yoshiki, Sakata, Yasushi

    Published in Scientific reports (19-07-2021)
    “…In contrast to hypertrophic cardiomyopathy, there has been reported no specific pattern of cardiomyocyte array in dilated cardiomyopathy (DCM), partially…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Targeted Genome Replacement via Homology-directed Repair in Non-dividing Cardiomyocytes by Ishizu, Takamaru, Higo, Shuichiro, Masumura, Yuki, Kohama, Yasuaki, Shiba, Mikio, Higo, Tomoaki, Shibamoto, Masato, Nakagawa, Akito, Morimoto, Sachio, Takashima, Seiji, Hikoso, Shungo, Sakata, Yasushi

    Published in Scientific reports (24-08-2017)
    “…Although high-throughput sequencing can elucidate the genetic basis of hereditary cardiomyopathy, direct interventions targeting pathological mutations have…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Risk of in-stent thrombus formation at one year after drug-eluting stent implantation by Higo, Tomoaki, Ueda, Yasunori, Matsuo, Koshi, Nishio, Mayu, Hirata, Akio, Asai, Mitsutoshi, Nemoto, Takayoshi, Murakami, Ayaka, Kashiwase, Kazunori, Kodama, Kazuhisa

    Published in Thrombosis research (01-11-2011)
    “…Abstract Introduction Although very late stent thrombosis is an important problem with drug-eluting stents, risks for in-stent thrombus formation have not been…”
    Get full text
    Journal Article
  15. 15

    Chronic Kidney Disease and Coronary Artery Vulnerable Plaques by Wada, Mitsuru, Ueda, Yasunori, Higo, Tomoaki, Matsuo, Koshi, Nishio, Mayu, Hirata, Akio, Asai, Mitsutoshi, Nemoto, Takayoshi, Kashiyama, Toshikazu, Murakami, Ayaka, Kashiwase, Kazunori, Kodama, Kazuhisa

    “…Chronic kidney disease (CKD) is a risk factor of cardiovascular disease. The number of yellow plaques is a predictor of future cardiovascular events. We…”
    Get full text
    Journal Article
  16. 16

    Atherosclerotic and Thrombogenic Neointima Formed Over Sirolimus Drug-Eluting Stent by Higo, Tomoaki, MD, Ueda, Yasunori, MD, PhD, Oyabu, Jota, MD, Okada, Katsuki, MD, Nishio, Mayu, MD, PhD, Hirata, Akio, MD, PhD, Kashiwase, Kazunori, MD, PhD, Ogasawara, Nobuyuki, MD, Hirotani, Shinichi, MD, PhD, Kodama, Kazuhisa, MD, PhD

    Published in JACC. Cardiovascular imaging (01-05-2009)
    “…Objectives We sought to examine by angioscopy the neointima formation and thrombogenic potential of the neointima after deployment of a drug-eluting stent…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Abstract 13026: Homogeneous 2D and 3D Alignment of Cardiomyocytes in Dilated Cardiomyopathy Revealed by Intravital Heart Imaging by Masuyama, Kiyoshi, Higo, Tomoaki, Lee, Jong-Kook, Miyagawa, Shigeru, Sawa, Yoshiki, Sakata, Yasushi

    Published in Circulation (New York, N.Y.) (17-11-2020)
    “…BackgroundIn contrast to hypertrophic cardiomyopathy, there has been reported no specific pattern of cardiomyocyte array in dilated cardiomyopathy (DCM). This…”
    Get full text
    Journal Article
  19. 19

    Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23 by Matsui, Isao, Oka, Tatsufumi, Kusunoki, Yasuo, Mori, Daisuke, Hashimoto, Nobuhiro, Matsumoto, Ayumi, Shimada, Karin, Yamaguchi, Satoshi, Kubota, Keiichi, Yonemoto, Sayoko, Higo, Tomoaki, Sakaguchi, Yusuke, Takabatake, Yoshitsugu, Hamano, Takayuki, Isaka, Yoshitaka

    Published in Kidney international (01-07-2018)
    “…Several experimental studies have shown that fibroblast growth factor 23 (FGF23) induces left ventricular hypertrophy (LVH). However, the opposite directional…”
    Get more information
    Journal Article
  20. 20